Rifamycin imino derivatives effective against drug-resistant microbes
View Patent ↗The present invention relates to rifamycin 3-iminomethylenyl (—CH═N—) derivatives having antimicrobial activities, including activities against drug-resistant microorganisms. The claimed rifamycin derivative has a rifamycin moiety covalently linked to a linker through an iminomethylenyl (—CH═N—) group at the C-3 carbon of the rifamycin moiety and the linker is, in turn, covalently linked to a quinolone structure or its pharmacophore within the DNA gyrase and topoisomerase IV inhibitor family. The inventive rifamycins are novel and exhibit activity against both rifampin and ciprofloxacin-resistant microorganisms.
1. A compound having a structural formula I:
wherein:
X is a linker group selected from one or a combination of two to three of the following groups:
(a) (C 1 -C 6 )alkylene,
(b) (C 3 -C 8 )cycloalkylene,
(c) arylene,
(d) bivalent heterocyclic group containing 1 to 3 heteroatoms,
(e) —C(═O)—,
(f) —C(═N—O—R 11 )—, wherein R 11 represents hydrogen, (C 1 -C 6 )alkyl, or substituted (C 1 -C 6 alkyl),
(g) —C═N—,
(h) —O—,
(i) —S(O) n —, wherein n is number between 0 and 2, and
(j) —N(R 12 )—, wherein R 12 represents hydrogen, (C 1 -C 6 )alkyl, or substituted (C 1 -C 6 alkyl),
wherein the carbon or nitrogen atoms of the linker group are optionally substituted by 1 to 3 substituents selected from (C 1 -C 6 )alkyl, substituted (C 1 -C 6 )alkyl, amino, (C 1 -C 6 )alkylamino, di(C 1 -C 6 )alkylamino, hydroxyl, or (C 1 -C 6 )alkoxy;
R i is (C 1 -C 6 )alkyl, (C 3 -C 6 )cycloalkyl, substituted (C 3 -C 6 )cycloalkyl, aryl, substituted aryl, heteroaryl, or substituted heteroaryl;
R ii is hydrogen, halogen, amino, nitro or methyl group;
Y is C—H, C—F, or N;
Z is C—H, C—F, C—CN, C—CF 3 , C—Cl, C—Me, C—OMe, C—OCH 2 F, C—OCHF 2 , or N; and
R is hydrogen, or acetyl,
or a pharmaceutically acceptable salt of the structural formula I.
2. The compound of claim 1 , wherein X is any one or a combination of the following structures:
3. A rifamycin compound having a structural formula I:
wherein,
R i is (C 1 -C 6 )alkyl, (C 3 -C 6 )cycloalkyl, substituted (C 3 -C 6 )cycloalkyl, aryl, substituted aryl, heteroaryl, or substituted heteroaryl;
R ii is hydrogen, halogen, amino, nitro or methyl group;
Y is C—H, C—F, or N;
Z is C—H, C—F, C—CN, C—CF 3 , C—Cl, C—Me, C—OMe, C—OCH 2 F, C—OCHF 2 , or N;
R is hydrogen or acetyl, and
X is a linker group selected from one or a combination of two to three of the following groups:
or a pharmaceutically acceptable salt of the structural formula I above.
4. A method of treating a bacterial infection in a subject comprising administering to the subject an effective amount of the compound of claim 1 .
5. The method of claim 4 , wherein the bacterial infection is caused by a drug-resistant bacterium.
6. A compound of the formula: 3-[4-(3-Carboxy-1-cyclopropl-6-fluoro-4-oxo-1,4-dihydroquinolin-7-yl)piperazin-1-yl-aminomethylenyl]rifamycin SV:
7. A compound of the formula: 3-[4-(3-Carboxy-1-cyclopropl-6-fluoro-4-oxo-1,4-dihydroquinolin-7-yl)-piperazin-1-yl-aminomethylenyl]rifamycin S:
8. A compound of the formula: (R/S)-3-[1-(8-chloro-3-carboxy-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinolin-7-yl)-pyrrolidin-3-ylhydrazinomethylenyl]rifamycin SV:
9. A compound of the formula: (R/S)-3-[4-(3-Carboxy-1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinolin-7-yl)-2-methyl-piperazin-1-yl-aminomethylenyl]rifamycin SV:
10. A compound of the formula: (R/S)-3-[4-(3-Carboxy-1-ethyl-6,8-difluoro-8-4-oxo-1,4-dihydroquinolin-7-yl)-2-methyl-piperazin-1-yl-aminomethylenyl]rifamycin SV:
11. A compound of the formula: (R/S)-3-[1-[3-Carboxy-1-(2,4-difluoro-phenyl)-6-fluoro-4-oxo-1,4-dihydro-[1,8]naphthyridin-7-yl]-pyrrolidinyl-3-hydrazinomethylenyl]rifamycin SV:
12. A compound of the formula: 3-[4-[3-Carboxy-1-(2,4-difluoro-phenyl)-6-fluoro-4-oxo-1,4-dihydro-[1,8]naphthyridine-7-yl]-piperazin-1-ylaminomethylenyl]rifamycin S:
13. A compound of the formula: (R/S)-3-[1-(3-Carboxy-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinolin-7-yl)-pyrrolidin-3-yl-N′-(1-methyl-piperidin-4-yl)-hydrazinomethylenyl]rifamycin SV:
14. A compound of the formula: (R/S)-3-[4-(3-Carboxy-1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinolin-7-yl)-2-methylpiperazin-1-yl-aminomethylenyl]rifamycin S:
15. A compound of the formula: 3-[6-(3-Carboxy-1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinolin-7-yl)-octahydropyrrolo[3,4-b]pyridin-1-yl-aminomethylenyl]rifamycin S:
16. A compound of the formula: 3-[4-(3-Carboxy-1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinolin-7-yl)-2-methyl-piperazin-1-yl-aminomethylenyl]-25-deacetyirifamycin S:
17. A compound of the formula: 3-[4-(3-Carboxy-1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinolin-7-yl)-2-methyl-piperazin-1-yl-aminomethylenyl]-25-deacetylrifamycin SV:
18. A compound of the formula: 3-[4-[3-Carboxy-1-(2,4-difluoro-phenyl)-6-fluoro-4-oxo-1,4-dihydro-[1,8]naphthyridine-7-yl]-piperazin-1-ylaminomethylenyl]rifamycin SV:
19. A compound of the formula: (R/S)-3-[1-(3-Carboxy-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinolin-7-yl)-pyrrolidin-3-yl-N′-methylhydrazinomethylenyl]rifamycin SV:
20. A compound of the formula: (R/S)-3-[(4-{1-[1-(3-Carboxy-1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-1,4-dihydro-quinoline-7-yl)-pyrrolidin-3-yl-cyclopropyl]-methyl)-amino}-piperidin-1-ylimino)-methyl]-rifamycin S:
21. A compound of the formula: (R/S)-3-{[4-({1-[1-(3-Carboxy-8-chloro-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-quinolin-7-yl)-pyrrolidin-3-yl]-cyclopropyyl}-methyl-amino)-piperidin-1-ylimino]-methyl}-rifamycin SV:
22. A compound of the formula: 3-[4-(3-Carboxy-1-ethyl-6-fluoro-4-oxo-1,4-dihydroquinolin-7-yl)-piperazin-1-yl-aminomethylenyl]-rifamycin SV:
23. A compound of the formula: 3-[4-(3-Carboxy-1-ethyl-6-fluoro-4-oxo-1,4-dihydro-[1,8]naphthyridine-7-yl)-piperazin-1-yl-aminomethylenyl]-rifamycin SV:
24. A compound of the formula: 3-[4-(3-Carboxy-1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinolin-7-yl)-piperazin-1-yl-aminomethylenyl]-rifamycin SV:
25. A compound of the formula: (R/S)-3-[1-(3-Carboxy-1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinolin-7-yl)-pyrrolidinyl-3-hydrazino-methylenyl]-yifamycin SV:
26. A compound of the formula: (R/S)-3-[1-(3-Carboxy-1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinolin-7-yl)-pyrrolidinyl-3-methylhydrazino-methylenlyl]-rifamycin SV:
27. A compound of the formula: (R/S)-3-[4-(3-Carboxy-1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinolin-7-yl)-3-carboxy-piperazin-1-yl-aminomethylenyl]-rifamycin SV:
28. A compound of the formula: (R/S)-3-[1-(3-Carboxy-1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinolin-7-yl)-piperidin-3-hydrazino-methylenyl]-rifamycin SV:
29. A compound of the formula: 3-{4-[1-(3-Carboxy-1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinolin-7-yl)-piperazin-4-yl]-piperidin-1-yl-aminomethylenyl}-rifamycin SV:
30. A compound of the formula: (R/S)-3-{4-[1-(3-Carboxy-1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinolin-7-yl)-pyrrolidin-3-ylamino]-piperidin-1-yl-aminomethylenyl}-rifamycin SV:
31. A compound of the formula: 3-{4-[1-(3-Carboxy-1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinolin-7-yl)-piperidin-4-yl]-piperazin-1-yl-aminomethylenyl}-rifamycin SV:
32. A compound of the formula: (R/S)-3-{3-[1-(3-carboxy-1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinolin-7-yl)-piperazin-4-yl]-pyrrolidinyl-1-hydrazino-methylenyl}-rifamycin SV:
33. A compound of the formula: (R/S)-3-[1-(3-Carboxy-1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinolin-7-yl)-pyrrolidinyl-3-isopropylhydrazino-methylenyl]-rifamycin SV:
34. A compound of the formula: (R/S)-3-[1-(3-carboxy-1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinolin-7-yl)-pyrrolidinyl-3-(pyridin-2-ylmethyl)hydrazino-methylenyl]-rifamycin SV:
35. A compound of the formula: (R/S)-3-{4-[1-(3-Carboxy-8-chloro-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinolin-7-yl)-pyrrolidin-3-ylcarbamoyl]-piperidin-1-yl-aminomethylenyl}-rifamycin SV:
36. A compound of the formula: 3-{4-[4-(3-Carboxy-1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinolin-7-yl)-piperazine-1-yl-carbonyl]-piperidin-1-yl-aminomethylenyl}-rifamycin SV:
37. A compound of the formula: (R/S)-3-{4-[1-(3-Carboxy-1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinolin-7-yl)-pyrrolidin-3-yl]-piperazin-1-yl-aminomethylenyl}-rifamycin SV:
38. A compound of the formula: (R/S)-3-{4-[1-(3-Carboxy-1-(2,3-difluoro-phenyl)-6-fluoro-4-oxo-1,4-dihydro[1,8]naphthyridine-7-yl)-pyrrolidin-3-yl]-piperazin-1-yl-aminomethylenyl}-rifamycin SV:
39. A compound of the formula: 3-[4-(3-Carboxy-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-[1,8]naphthyridine-7-yl)-piperazin-1-yl-aminomethylenyl]-rifamycin SV:
40. A compound of the formula: (R/S)-3-{4-[1-(3-Carboxy-1-(2,4-difluoro-phenyl)-6-fluoro-4-oxo-1,4-dihydro-[1,8]naphthyridine-7-yl)-pyrrolidin-3-yl-carbonyl]-piperazin-1-yl-aminomethylenyl}-rifamycin SV:
41. A compound of the formula: (R/S)-3-{4-[1-(3-Carboxy-1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-7-yl)-pyrrolidin-3-yl-cyclopropyl]-piperazin-1-yl-aminomethylenyl}-rifamycin SV:
42. A compound of the formula: (R/S)-3-{4-[1-(3-Carboxy-8-chloro-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline-7-yl)-pyrrolidin-3-yl-cyclopropyl]-piperazin-1-yl-aminomethylenyl}-rifamycin SV:
43. A compound of the formula: (R/S)-3-[1-(3-Carboxy-8-chloro-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline-7-yl)-pyrrolidin-3-yl-methyl-hydrazino-methylenyl]-rifamycin SV:
44. A compound of the formula: 3-[4-(3-Carboxy-8-chloro-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinolin-7-yl)-piperazin-1-yl-aminomethylenyl]-rifamycin SV:
45. A compound of the formula: 3-{4-[1-(3-Carboxy-1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinolin-7-yl)-pyrrolidin-3-yl-ethylamino]-piperidin-1-yl-aminomethylenyl}-rifamycin SV:
46. A compound of the formula: 3-({1-[1-(3-Carboxy-1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-1,4-dihydro-quinolin-7-yl)-pyrrolidin-3-yl]-ethyl}-hydrazinomethylenyl)-rifamycin SV:
47. A compound of the formula: (R/S)-3-[1-[3-Carboxy-1-(2,4-difluoro-phenyl)-6-fluoro-4-oxo-1,4-dihydro-[1,8]naphthyridin-7-yl]-pyrrolidinyl-3-methylhydrazinomethylenyl]rifamycin SV:
48. A compound of the formula: (R/S)-3-[9-fluoro-3-methyl-10-(3-methyl-piperazin-1-hydrazinomethylenyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid]rifamycin SV:
49. A compound of the formula: (R/S)-3-[4-[1-[1-(3-Carboxy-1-cyclopropyl-7-fluoro-8-chloro-4-oxo-4H-quinolin-7-yl)pyrrolidin-3-yl]cycloprop-1-ylamino]piperidin-1-ylaminomethylenyl]rifamycin SV:
50. A compound of the formula: (R/S)-3-[4-[1-[1-(3-Carboxy-1-cyclopropyl-7-fluoro-8-methoxy-4-oxo-4H-quinolin-7-yl)pyrrolidin-3-yl]cycloprop-1-ylamino]piperidin-1-ylaminomethyl]rifamycin SV:
51. A compound of the formula: (R/S)-3-{[4-({1-[1-(3-Carboxy-1-(2,3-difluoro-phenyl)-6-fluoro-4-oxo-1,4-dihydro[1,8]naphthyridine-7-yl)-pyrrolidin-3-yl]-cyclopropyl}-methyl-amino)-piperidin-1-ylimino]-methyl}-rifamycin SV: